Dollar Weakens; Vaccines and Likely Stimulus Buoys Risk Appetite By Investing.com


© Reuters.

By Peter Nurse

Investing.com – The dollar continued to weaken in early European trade Wednesday, with riskier currencies more in vogue as investors look to the new administration in the U.S. for additional stimulus amid solid progress towards Covid-19 vaccines.

At 3:55 AM ET (0755 GMT), the Dollar Index, which tracks the greenback against a basket of six other currencies, was down 0.2% at 92.052. 

climbed 0.2% to 1.1908, close to a two-month high, rose 0.2% to 1.3376, close to its highest level in more than two months, while was largely flat at 104.44.

The greenback is also close to a two-month low against the and a two-year low against the , both considered barometers of risk sentiment due to their close ties with the global commodities trade.

Risk appetite has improved after the outgoing President Donald Trump’s administration began cooperating with the transition to a Joe Biden presidency, and after reports that former Federal Reserve head Janet Yellen, an advocate of bigger fiscal stimulus, is set to become Treasury Secretary.

This has added to the general optimism surrounding the likelihood of the prompt delivery of multiple Covid-19 vaccines, with positive news from Pfizer (NYSE:), Moderna (NASDAQ:) and AstraZeneca (NASDAQ:) of their trials over the last couple of weeks.

“2021 will be the year that FX markets, diverted by two years of President Trump’s protectionism and then by one year of the Covid-19 crisis, get back on track as the gravitational pull of the dollar fades,” said ING’s Chris Turner, in a research note. “We forecast the dollar to broadly decline in 2021 – generally by 5-10% against most currencies.”

There is an abundance of U.S. economic data due for release later in the session, ahead of Thursday’s Thanksgiving holiday, including the Federal Reserve’s of the most recent Federal Open Market Committee meeting, U.S. and data.

Sterling will remain in focus Wednesday, remaining bid as traders expect a trade deal to be agreed between the U.K. and the European Union in the near future given the end of year deadline and recent optimistic noises emerging from the talks.

On Tuesday, influential U.S. investment bank JPMorgan (NYSE:) raised its odds of a Brexit trade deal to 80%, up from two-thirds.

“Since the summer we have put the odds of a deal at about two-thirds, and no-deal at a third,” JPMorgan said in a note to clients. “Given the recent newsflow, the likelihood of a deal is clearly growing, and hence we shift our assessment to 80-20 in favour of a deal.”

 

Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All CFDs (stocks, indexes, futures) and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn`t bear any responsibility for any trading losses you might incur as a result of using this data.

Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.





Source link

LEAVE A REPLY

Please enter your comment!
Please enter your name here